// App-Quantinova.ai

42 : Prognosis of Seronegative Patients in a Large Prospective Cohort of Patients with Early Inflammatory Arthritis

Researchers

Presenter

  • Janet Pope

Principal Investigators

  • Boulos Haraoui

  • Carol Hitchon

  • Carter Thorne

  • Edward Keystone

  • Diane Tin

  • Gilles Boire

  • Vivian Bykerk

Medical Centers

  • London,Canada

  • Univ of Manitoba, Winnipeg, Canada

  • Mount Sinai Hospital, Toronto, ON, Canada

  • Hospital for Special Surgery, New York, NY.

  • Universite de Sherbrooke, Sherbrooke, QC, Canada

  • University of Western Ontario, London, ON, Canada

  • U of T, Toronto,Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Early inflammatory arthritis

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved